Alps Advisors Inc. Makes New $500,000 Investment in BWX Technologies, Inc. $BWXT

Alps Advisors Inc. bought a new stake in shares of BWX Technologies, Inc. (NYSE:BWXT) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,710 shares of the technology company’s stock, valued at approximately $500,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Goldman Sachs Group Inc. raised its stake in BWX Technologies by 0.3% in the first quarter. Goldman Sachs Group Inc. now owns 141,680 shares of the technology company’s stock valued at $13,977,000 after buying an additional 371 shares in the last quarter. Caxton Associates LLP purchased a new position in BWX Technologies during the first quarter worth about $304,000. Concurrent Investment Advisors LLC lifted its holdings in BWX Technologies by 8.5% in the second quarter. Concurrent Investment Advisors LLC now owns 6,925 shares of the technology company’s stock valued at $998,000 after acquiring an additional 544 shares during the period. Vanguard Personalized Indexing Management LLC increased its stake in BWX Technologies by 12.3% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 8,909 shares of the technology company’s stock valued at $1,283,000 after purchasing an additional 978 shares in the last quarter. Finally, CWM LLC boosted its position in shares of BWX Technologies by 6.4% in the 2nd quarter. CWM LLC now owns 2,703 shares of the technology company’s stock worth $389,000 after buying an additional 163 shares in the last quarter. 94.39% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. CJS Securities raised BWX Technologies to a “strong-buy” rating in a research note on Friday, December 12th. Truist Financial set a $205.00 price target on shares of BWX Technologies in a research report on Friday, January 9th. BTIG Research increased their price objective on shares of BWX Technologies from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, November 7th. Wall Street Zen upgraded BWX Technologies from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Finally, Weiss Ratings cut shares of BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 26th. Three research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, BWX Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $199.20.

BWX Technologies Trading Down 0.8%

Shares of NYSE:BWXT opened at $196.99 on Friday. The company has a 50 day moving average price of $192.20 and a 200 day moving average price of $184.40. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.62 and a current ratio of 1.71. The stock has a market capitalization of $18.01 billion, a price-to-earnings ratio of 59.16, a PEG ratio of 3.19 and a beta of 0.84. BWX Technologies, Inc. has a 1-year low of $84.21 and a 1-year high of $220.57.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.